Manufacture of a monoclonal antibody for use as a single-step immunoselection of blood dendritic cells aiding in the development of a patient-specific cancer vaccine (2020-2021)
Experts
Dr
Martina Jones
Research Fellow
Australian Institute for Bioengineering and Nanotechnology
